Travere Therapeutics Stock Is Trading Higher On Positive Data From Kidney Disease Candidate
Regulus's Polycystic Kidney Disease Candidate Shows Benefit At Interim Analysis
Regulus Therapeutics' RGLS4326 Reports Mixed Bag On Polycystic Kidney Disease-Associated Biomarker Study
AstraZeneca's Diabetes Drug Farxiga Scores FDA Nod In Kidney Disease
Kidney Disease Recent News
Renalytix AI Stock Jumps After 10-Year US Government Contract For Kidney Disease Testing Services
Calliditas Starts Dosing In Nefecon Open Label Extension Study In Kidney Disease
Chinook Therapeutics Nabs Rare Pediatric Disease Tag For CHK-336 In Primary Hyperoxaluria
3 Companies Filed For Chapter 11 Bankruptcy Today
Akebia Therapeutics Lower Following Announcement Of Public Offering, Corporate And Clinical Developments
Thanks, FDA: NephroGenex Investors Rejoice After New Clearance